Atomwise Company

Atomwise uses artificial intelligence for drug discovery. We design new molecules for the hardest targets. Our discoveries help our partners deliver better medicines faster.


Connections from

Founded Date: 2012-01-01
Total Funding: 176645000.0
Investor Type: For Profit
Employee Number: 94
Funding Status: Early Stage Venture
Technology: ['BioTech & HealthTech']
Last Funding Type: Grant
Investors Number: 22.0
Last Funding Date: 2020-10-06
Industry: Application Software
Headquarters: United
Estimated Revenue: 2.3